Search results
Unveiling Viatris (VTRS)'s Value: Is It Really Priced Right? A C
Guru Focus· 3 hours agoWith a Loss Per Share of 0.06, the question arises: is Viatris modestly overvalued? This article delves into a detailed valuation analysis to help investors make informed decisions. Viatris ...
Got $1,000? 3 Dividend Stocks to Buy and Hold Forever | The Motley Fool
The Motley Fool· 7 days agoHere is why Johnson & Johnson (JNJ -0.21%), Abbott Labs (ABT 0.04%), and Pfizer (PFE -0.55%) should...
Investing in Pfizer Inc.
Knox Daily· 2 days agoArgus downgraded its Pfizer Inc. [PFE] rating to a Hold from a a Buy in a research...revised their coverage, including Guggenheim’s analysts, who began to cover the
Does Soaring Novavax Stock Have Enough Fuel to Climb Higher?
Motley Fool via Yahoo Finance· 18 hours agoThe Motley Fool has positions in and recommends Pfizer. The Motley Fool recommends Moderna. The...
Healthcare Giants Pfizer, AstraZeneca, Sanofi Inject Over $2B To Boost France's Healthcare Sector -...
Benzinga· 1 day agoPfizer and AstraZeneca invest over $1 billion in France's healthcare sector, bolstering R&D...
Decoding Pfizer Inc (PFE): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 5 days agoOverall, Pfizer's SWOT analysis reveals a company with the resources and capabilities to adapt and thrive...specific investment guidance. It does not...
This 6% Yielding Dividend Stock Could Pump Up Your Passive-Income Stream
Motley Fool via Yahoo Finance· 6 days agoWith an ultra-high dividend yield and heaps of new drugs that can help it raise its payout, Pfizer...
Spotlight on Pfizer: Analyzing the Surge in Options Activity - Pfizer (NYSE:PFE)
Benzinga· 5 days agoRSI indicators hint that the underlying stock may be approaching overbought. Next earnings are expected to be released in 82 days. Professional Analyst Ratings for
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks With Over 5% Dividend Yields - ...
Benzinga· 5 days agoTraders can sort through Benzinga's extensive...ratings of the most accurate analysts for three...
A Struggling Pfizer Looks for Help From a Wall Streeter
Barrons.com· 4 days agoAs the big drugmaker tries to turn its fortunes around by focusing on oncology, it has turned to a...
